Shopping Cart 0
Cart Subtotal
AED 0

Surgical Sutures - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 14680

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 29360

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 44040

Details

Surgical Sutures-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Surgical Sutures-Medical Devices Pipeline Assessment, 2018" provides an overview of Surgical Sutures currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Sutures pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Surgical Sutures under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Surgical Sutures and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Surgical Sutures under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 Surgical Sutures Overview 8

3 Products under Development 9

3.1 Surgical Sutures-Pipeline Products by Stage of Development 9

3.2 Surgical Sutures-Pipeline Products by Segment 10

3.3 Surgical Sutures-Pipeline Products by Territory 11

3.4 Surgical Sutures-Pipeline Products by Regulatory Path 12

3.5 Surgical Sutures-Pipeline Products by Estimated Approval Date 13

3.6 Surgical Sutures-Ongoing Clinical Trials 14

4 Surgical Sutures-Pipeline Products under Development by Companies 15

4.1 Surgical Sutures Companies-Pipeline Products by Stage of Development 15

4.2 Surgical Sutures-Pipeline Products by Stage of Development 16

5 Surgical Sutures Companies and Product Overview 17

5.1 Advanced Suture Company Overview 17

5.1.1 Advanced Suture Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Archon Medical Technologies LLC Company Overview 18

5.2.1 Archon Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 BioSurfaces, Inc. Company Overview 19

5.3.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 CorMedix Inc Company Overview 20

5.4.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Ethicon US LLC Company Overview 21

5.5.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Indian Institute of Technology Bombay Company Overview 27

5.6.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Indian Institute of Technology Delhi Company Overview 28

5.7.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Innovation Pharmaceuticals Inc Company Overview 29

5.8.1 Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Johns Hopkins University Company Overview 30

5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Mellon Medical B.V. Company Overview 31

5.10.1 Mellon Medical B.V. Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 MiMedx Group Inc Company Overview 35

5.11.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Nobles Medical Technology, Inc. Company Overview 36

5.12.1 Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 NuVascular Technologies Inc Company Overview 38

5.13.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Resorba GmbH Company Overview 39

5.14.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Scarless Laboratories Inc Company Overview 42

5.15.1 Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Silver Bullet Therapeutics, Inc. Company Overview 43

5.16.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Tepha Inc Company Overview 44

5.17.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 TissueGen Inc Company Overview 45

5.18.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Universidade Nova de Lisboa Company Overview 46

5.19.1 Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 University of North Carolina at Chapel Hill Company Overview 47

5.20.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Visionary Medical Supplies, Inc. Company Overview 48

5.21.1 Visionary Medical Supplies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 VitaThreads, LLC Company Overview 49

5.22.1 VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

6 Surgical Sutures- Recent Developments 50

6.1 Jun 07, 2018: MiMedx to restate certain historical financial statements 50

6.2 Jun 07, 2018: MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress 51

6.3 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO 52

6.4 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 52

6.5 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 53

6.6 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 54

6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 56

6.8 Apr 26, 2018: MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance 57

6.9 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 58

6.10 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 59

6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 60

6.12 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 61

6.13 Mar 15, 2018: MiMedx Announces Expectation to Exceed the USD92 Million Top End of First Quarter Revenue Guidance 63

6.14 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017 64

6.15 Mar 06, 2018: Financial year 2017: COLTENE grows faster than the market-EBIT margin rises above the 15% mark 71

6.16 Mar 03, 2018: Arthrex Announces New Vice President of Strategic Development 73

6.17 Mar 02, 2018: MiMedx Receives Notice of Filing Delinquency from NASDAQ 73

6.18 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 74

6.19 Feb 14, 2018: Centenial Surgical Suture: Re-appointment of Ms. Anuradha Kashikar, as an Executive Director & Chief Financial Officer 75

6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 75

6.21 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results 76

6.22 Jan 31, 2018: COLTENE reports pleasing growth for fiscal 2017 77

6.23 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 78

6.24 Jan 18, 2018: DSM appoints Wilfrid Gambade as President DSM Dyneema 78

6.25 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 79

6.26 Jan 07, 2018: MiMedx Releases Preliminary 2017 Revenue of USD324.5M Representing a 32% Increase Over 2016 79

6.27 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer 81

6.28 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 82

6.29 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 83

6.30 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 83

6.31 Nov 09, 2017: Arthrex Announces Plans for Expansion of Global Headquarters 86

6.32 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 87

6.33 Nov 08, 2017: Tepha Announces Regenerative Medicine Recent Developments and R & D Initiatives 88

6.34 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes 89

6.35 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 89

6.36 Nov 02, 2017: CONMED Announces Retirement of Chief Financial Officer 90

6.37 Nov 02, 2017: CONMED Announces Third Quarter 2017 Financial Results 91

6.38 Nov 01, 2017: MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions 92

6.39 Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At Obesity Week 2017 92

6.40 Oct 26, 2017: MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance 94

6.41 Oct 25, 2017: Bard Announces Third Quarter Results 97

6.42 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 99

6.43 Oct 16, 2017: Arthrex Announces Plans for New Surgical Device Manufacturing Facility 100

6.44 Oct 10, 2017: MiMedx Announces Third Quarter Revenues Of USD84.6 Million Exceeds Guidance By More Than 5 Percent 101

6.45 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 102

6.46 Oct 04, 2017: MiMedx Files Lawsuit Related To Short Seller Attacks 103

6.47 Oct 03, 2017: COLTENE plans an extension of its headquarters in Altstaetten, Switzerland 104

6.48 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 105

6.49 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 105

6.50 Sep 21, 2017: MiMedx Files Lawsuit Against The Capitol Forum 106

6.51 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 106

6.52 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 107

6.53 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed USD80 Million Despite Hurricane Irma 108

6.54 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 109

6.55 Aug 17, 2017: ECRI Institute Releases Groundbreaking Evaluation of Surgical Sutures 111

6.56 Aug 04, 2017: COLTENE: Increase in Sales and Improved EBIT Margin 112

6.57 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 113

6.58 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 113

6.59 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 114

6.60 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 115

6.61 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 117

6.62 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 118

6.63 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 119

6.64 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 120

7 Appendix 121

7.1 Methodology 121

7.2 About GlobalData 124

7.3 Contact Us 124

7.4 Disclaimer 124


List Of Figure

1.2 List of Figures

Figure 1: Surgical Sutures-Pipeline Products by Stage of Development 9

Figure 2: Surgical Sutures-Pipeline Products by Segment 10

Figure 3: Surgical Sutures-Pipeline Products by Territory 11

Figure 4: Surgical Sutures-Pipeline Products by Regulatory Path 12

Figure 5: Surgical Sutures-Pipeline Products by Estimated Approval Date 13

Figure 6: Surgical Sutures-Ongoing Clinical Trials 14


List Of Table

1.1 List of Tables

Table 1: Surgical Sutures-Pipeline Products by Stage of Development 9

Table 2: Surgical Sutures-Pipeline Products by Segment 10

Table 3: Surgical Sutures-Pipeline Products by Territory 11

Table 4: Surgical Sutures-Pipeline Products by Regulatory Path 12

Table 5: Surgical Sutures-Pipeline Products by Estimated Approval Date 13

Table 6: Surgical Sutures-Ongoing Clinical Trials 14

Table 7: Surgical Sutures Companies-Pipeline Products by Stage of Development 15

Table 8: Surgical Sutures-Pipeline Products by Stage of Development 16

Table 9: Advanced Suture Pipeline Products & Ongoing Clinical Trials Overview 17

Table 10: Mesh Suture-Product Status 17

Table 11: Mesh Suture-Product Description 17

Table 12: Archon Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

Table 13: FastStitch Device-Product Status 18

Table 14: FastStitch Device-Product Description 18

Table 15: BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 16: Drug-Eluting Sutures-Product Status 19

Table 17: Drug-Eluting Sutures-Product Description 19

Table 18: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 19: Taurolidine Sutures-Product Status 20

Table 20: Taurolidine Sutures-Product Description 20

Table 21: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 22: Additional PLUS Barbed Suture-Product Status 21

Table 23: Additional PLUS Barbed Suture-Product Description 21

Table 24: VICRYL (Polydactin 910)-Next Gen-Product Status 22

Table 25: VICRYL (Polydactin 910)-Next Gen-Product Description 22

Table 26: Vicryl Rapide Plus Suture-Product Status 22

Table 27: Vicryl Rapide Plus Suture-Product Description 23

Table 28: Ethicon US LLC-Ongoing Clinical Trials Overview 24

Table 29: Vicryl Rapide Plus Suture-Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 25

Table 30: Vicryl Rapide Plus Suture-Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 25

Table 31: VICRYL (Polydactin 910)-Next Gen-Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 26

Table 32: VICRYL (Polydactin 910)-Next Gen-Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 26

Table 33: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 27

Table 34: Suturing Device-Product Status 27

Table 35: Suturing Device-Product Description 27

Table 36: Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 28

Table 37: Antimicrobial Sutures-Product Status 28

Table 38: Antimicrobial Sutures-Product Description 28

Table 39: Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 40: Antimicrobial Suture-Product Status 29

Table 41: Antimicrobial Suture-Product Description 29

Table 42: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

Table 43: Drug-Loaded Microfiber Suture-Product Status 30

Table 44: Drug-Loaded Microfiber Suture-Product Description 30

Table 45: Mellon Medical B.V. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 46: Switch-10cm Model-Product Status 31

Table 47: Switch-10cm Model-Product Description 31

Table 48: Switch-11cm Model-Product Status 32

Table 49: Switch-11cm Model-Product Description 32

Table 50: Switch-Laparoscopic Model-Product Status 32

Table 51: Switch-Laparoscopic Model-Product Description 33

Table 52: Switch-Micro Surgery Model-Product Status 33

Table 53: Switch-Micro Surgery Model-Product Description 33

Table 54: Switch-Robotic Version-Product Status 34

Table 55: Switch-Robotic Version-Product Description 34

Table 56: MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 57: CollaFix Collagen Fiber Suture-Product Status 35

Table 58: CollaFix Collagen Fiber Suture-Product Description 35

Table 59: Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

Table 60: SuperStitch ASD II-Product Status 36

Table 61: SuperStitch ASD II-Product Description 36

Table 62: SuperStitch II-Product Status 37

Table 63: SuperStitch II-Product Description 37

Table 64: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 65: NuSpun Arteriovenous Suture-Product Status 38

Table 66: NuSpun Arteriovenous Suture-Product Description 38

Table 67: Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

Table 68: RESOCAT CHROM SUTURE-Product Status 39

Table 69: RESOCAT CHROM SUTURE-Product Description 39

Table 70: RESOCAT PLAIN-Product Status 40

Table 71: RESOCAT PLAIN-Product Description 40

Table 72: SUPRAMID EXTRA SUTURE-Product Status 40

Table 73: SUPRAMID EXTRA SUTURE-Product Description 41

Table 74: Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 75: Peptide-Coated Suture-Product Status 42

Table 76: Peptide-Coated Suture-Product Description 42

Table 77: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Table 78: Galvanis Suture-Product Status 43

Table 79: Galvanis Suture-Product Description 43

Table 80: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 81: TephaFLEX Absorbable Multifilament Fiber-Product Status 44

Table 82: TephaFLEX Absorbable Multifilament Fiber-Product Description 44

Table 83: TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 84: ELUTE Fiber-Smart Suture-Product Status 45

Table 85: ELUTE Fiber-Smart Suture-Product Description 45

Table 86: Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 46

Table 87: Nanosuture-Product Status 46

Table 88: Nanosuture-Product Description 46

Table 89: University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 47

Table 90: Angiogenic Suture-Product Status 47

Table 91: Angiogenic Suture-Product Description 47

Table 92: Visionary Medical Supplies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 93: Sutrazorb Absorbable PGA Suture-Product Status 48

Table 94: Sutrazorb Absorbable PGA Suture-Product Description 48

Table 95: VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Table 96: VitaSuture Wound Management System-Product Status 49

Table 97: VitaSuture Wound Management System-Product Description 49

Table 98: Glossary 123

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Advanced Suture

Archon Medical Technologies LLC

BioSurfaces, Inc.

CorMedix Inc

Ethicon US LLC

Indian Institute of Technology Bombay

Indian Institute of Technology Delhi

Innovation Pharmaceuticals Inc

Johns Hopkins University

Mellon Medical B.V.

MiMedx Group Inc

Nobles Medical Technology, Inc.

NuVascular Technologies Inc

Resorba GmbH

Scarless Laboratories Inc

Silver Bullet Therapeutics, Inc.

Tepha Inc

TissueGen Inc

Universidade Nova de Lisboa

University of North Carolina at Chapel Hill

Visionary Medical Supplies, Inc.

VitaThreads, LLC

Company Profile

Company Profile Title

Surgical Sutures-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Surgical Sutures-Medical Devices Pipeline Assessment, 2018" provides an overview of Surgical Sutures currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Sutures pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Surgical Sutures under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Surgical Sutures and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Surgical Sutures under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 Surgical Sutures Overview 8

3 Products under Development 9

3.1 Surgical Sutures-Pipeline Products by Stage of Development 9

3.2 Surgical Sutures-Pipeline Products by Segment 10

3.3 Surgical Sutures-Pipeline Products by Territory 11

3.4 Surgical Sutures-Pipeline Products by Regulatory Path 12

3.5 Surgical Sutures-Pipeline Products by Estimated Approval Date 13

3.6 Surgical Sutures-Ongoing Clinical Trials 14

4 Surgical Sutures-Pipeline Products under Development by Companies 15

4.1 Surgical Sutures Companies-Pipeline Products by Stage of Development 15

4.2 Surgical Sutures-Pipeline Products by Stage of Development 16

5 Surgical Sutures Companies and Product Overview 17

5.1 Advanced Suture Company Overview 17

5.1.1 Advanced Suture Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Archon Medical Technologies LLC Company Overview 18

5.2.1 Archon Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 BioSurfaces, Inc. Company Overview 19

5.3.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 CorMedix Inc Company Overview 20

5.4.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Ethicon US LLC Company Overview 21

5.5.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Indian Institute of Technology Bombay Company Overview 27

5.6.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Indian Institute of Technology Delhi Company Overview 28

5.7.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Innovation Pharmaceuticals Inc Company Overview 29

5.8.1 Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Johns Hopkins University Company Overview 30

5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Mellon Medical B.V. Company Overview 31

5.10.1 Mellon Medical B.V. Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 MiMedx Group Inc Company Overview 35

5.11.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Nobles Medical Technology, Inc. Company Overview 36

5.12.1 Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 NuVascular Technologies Inc Company Overview 38

5.13.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Resorba GmbH Company Overview 39

5.14.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Scarless Laboratories Inc Company Overview 42

5.15.1 Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Silver Bullet Therapeutics, Inc. Company Overview 43

5.16.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Tepha Inc Company Overview 44

5.17.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 TissueGen Inc Company Overview 45

5.18.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Universidade Nova de Lisboa Company Overview 46

5.19.1 Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 University of North Carolina at Chapel Hill Company Overview 47

5.20.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Visionary Medical Supplies, Inc. Company Overview 48

5.21.1 Visionary Medical Supplies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 VitaThreads, LLC Company Overview 49

5.22.1 VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

6 Surgical Sutures- Recent Developments 50

6.1 Jun 07, 2018: MiMedx to restate certain historical financial statements 50

6.2 Jun 07, 2018: MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress 51

6.3 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO 52

6.4 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 52

6.5 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 53

6.6 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 54

6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 56

6.8 Apr 26, 2018: MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance 57

6.9 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 58

6.10 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 59

6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 60

6.12 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 61

6.13 Mar 15, 2018: MiMedx Announces Expectation to Exceed the USD92 Million Top End of First Quarter Revenue Guidance 63

6.14 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017 64

6.15 Mar 06, 2018: Financial year 2017: COLTENE grows faster than the market-EBIT margin rises above the 15% mark 71

6.16 Mar 03, 2018: Arthrex Announces New Vice President of Strategic Development 73

6.17 Mar 02, 2018: MiMedx Receives Notice of Filing Delinquency from NASDAQ 73

6.18 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 74

6.19 Feb 14, 2018: Centenial Surgical Suture: Re-appointment of Ms. Anuradha Kashikar, as an Executive Director & Chief Financial Officer 75

6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 75

6.21 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results 76

6.22 Jan 31, 2018: COLTENE reports pleasing growth for fiscal 2017 77

6.23 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 78

6.24 Jan 18, 2018: DSM appoints Wilfrid Gambade as President DSM Dyneema 78

6.25 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 79

6.26 Jan 07, 2018: MiMedx Releases Preliminary 2017 Revenue of USD324.5M Representing a 32% Increase Over 2016 79

6.27 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer 81

6.28 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 82

6.29 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 83

6.30 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 83

6.31 Nov 09, 2017: Arthrex Announces Plans for Expansion of Global Headquarters 86

6.32 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 87

6.33 Nov 08, 2017: Tepha Announces Regenerative Medicine Recent Developments and R & D Initiatives 88

6.34 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes 89

6.35 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 89

6.36 Nov 02, 2017: CONMED Announces Retirement of Chief Financial Officer 90

6.37 Nov 02, 2017: CONMED Announces Third Quarter 2017 Financial Results 91

6.38 Nov 01, 2017: MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions 92

6.39 Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At Obesity Week 2017 92

6.40 Oct 26, 2017: MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance 94

6.41 Oct 25, 2017: Bard Announces Third Quarter Results 97

6.42 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 99

6.43 Oct 16, 2017: Arthrex Announces Plans for New Surgical Device Manufacturing Facility 100

6.44 Oct 10, 2017: MiMedx Announces Third Quarter Revenues Of USD84.6 Million Exceeds Guidance By More Than 5 Percent 101

6.45 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 102

6.46 Oct 04, 2017: MiMedx Files Lawsuit Related To Short Seller Attacks 103

6.47 Oct 03, 2017: COLTENE plans an extension of its headquarters in Altstaetten, Switzerland 104

6.48 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 105

6.49 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 105

6.50 Sep 21, 2017: MiMedx Files Lawsuit Against The Capitol Forum 106

6.51 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 106

6.52 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 107

6.53 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed USD80 Million Despite Hurricane Irma 108

6.54 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 109

6.55 Aug 17, 2017: ECRI Institute Releases Groundbreaking Evaluation of Surgical Sutures 111

6.56 Aug 04, 2017: COLTENE: Increase in Sales and Improved EBIT Margin 112

6.57 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 113

6.58 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 113

6.59 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 114

6.60 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 115

6.61 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 117

6.62 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 118

6.63 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 119

6.64 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 120

7 Appendix 121

7.1 Methodology 121

7.2 About GlobalData 124

7.3 Contact Us 124

7.4 Disclaimer 124


List Of Figure

1.2 List of Figures

Figure 1: Surgical Sutures-Pipeline Products by Stage of Development 9

Figure 2: Surgical Sutures-Pipeline Products by Segment 10

Figure 3: Surgical Sutures-Pipeline Products by Territory 11

Figure 4: Surgical Sutures-Pipeline Products by Regulatory Path 12

Figure 5: Surgical Sutures-Pipeline Products by Estimated Approval Date 13

Figure 6: Surgical Sutures-Ongoing Clinical Trials 14


List Of Table

1.1 List of Tables

Table 1: Surgical Sutures-Pipeline Products by Stage of Development 9

Table 2: Surgical Sutures-Pipeline Products by Segment 10

Table 3: Surgical Sutures-Pipeline Products by Territory 11

Table 4: Surgical Sutures-Pipeline Products by Regulatory Path 12

Table 5: Surgical Sutures-Pipeline Products by Estimated Approval Date 13

Table 6: Surgical Sutures-Ongoing Clinical Trials 14

Table 7: Surgical Sutures Companies-Pipeline Products by Stage of Development 15

Table 8: Surgical Sutures-Pipeline Products by Stage of Development 16

Table 9: Advanced Suture Pipeline Products & Ongoing Clinical Trials Overview 17

Table 10: Mesh Suture-Product Status 17

Table 11: Mesh Suture-Product Description 17

Table 12: Archon Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 18

Table 13: FastStitch Device-Product Status 18

Table 14: FastStitch Device-Product Description 18

Table 15: BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 16: Drug-Eluting Sutures-Product Status 19

Table 17: Drug-Eluting Sutures-Product Description 19

Table 18: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 19: Taurolidine Sutures-Product Status 20

Table 20: Taurolidine Sutures-Product Description 20

Table 21: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 22: Additional PLUS Barbed Suture-Product Status 21

Table 23: Additional PLUS Barbed Suture-Product Description 21

Table 24: VICRYL (Polydactin 910)-Next Gen-Product Status 22

Table 25: VICRYL (Polydactin 910)-Next Gen-Product Description 22

Table 26: Vicryl Rapide Plus Suture-Product Status 22

Table 27: Vicryl Rapide Plus Suture-Product Description 23

Table 28: Ethicon US LLC-Ongoing Clinical Trials Overview 24

Table 29: Vicryl Rapide Plus Suture-Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 25

Table 30: Vicryl Rapide Plus Suture-Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 25

Table 31: VICRYL (Polydactin 910)-Next Gen-Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 26

Table 32: VICRYL (Polydactin 910)-Next Gen-Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 26

Table 33: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 27

Table 34: Suturing Device-Product Status 27

Table 35: Suturing Device-Product Description 27

Table 36: Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 28

Table 37: Antimicrobial Sutures-Product Status 28

Table 38: Antimicrobial Sutures-Product Description 28

Table 39: Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 40: Antimicrobial Suture-Product Status 29

Table 41: Antimicrobial Suture-Product Description 29

Table 42: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30

Table 43: Drug-Loaded Microfiber Suture-Product Status 30

Table 44: Drug-Loaded Microfiber Suture-Product Description 30

Table 45: Mellon Medical B.V. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 46: Switch-10cm Model-Product Status 31

Table 47: Switch-10cm Model-Product Description 31

Table 48: Switch-11cm Model-Product Status 32

Table 49: Switch-11cm Model-Product Description 32

Table 50: Switch-Laparoscopic Model-Product Status 32

Table 51: Switch-Laparoscopic Model-Product Description 33

Table 52: Switch-Micro Surgery Model-Product Status 33

Table 53: Switch-Micro Surgery Model-Product Description 33

Table 54: Switch-Robotic Version-Product Status 34

Table 55: Switch-Robotic Version-Product Description 34

Table 56: MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 57: CollaFix Collagen Fiber Suture-Product Status 35

Table 58: CollaFix Collagen Fiber Suture-Product Description 35

Table 59: Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

Table 60: SuperStitch ASD II-Product Status 36

Table 61: SuperStitch ASD II-Product Description 36

Table 62: SuperStitch II-Product Status 37

Table 63: SuperStitch II-Product Description 37

Table 64: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 65: NuSpun Arteriovenous Suture-Product Status 38

Table 66: NuSpun Arteriovenous Suture-Product Description 38

Table 67: Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

Table 68: RESOCAT CHROM SUTURE-Product Status 39

Table 69: RESOCAT CHROM SUTURE-Product Description 39

Table 70: RESOCAT PLAIN-Product Status 40

Table 71: RESOCAT PLAIN-Product Description 40

Table 72: SUPRAMID EXTRA SUTURE-Product Status 40

Table 73: SUPRAMID EXTRA SUTURE-Product Description 41

Table 74: Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 75: Peptide-Coated Suture-Product Status 42

Table 76: Peptide-Coated Suture-Product Description 42

Table 77: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Table 78: Galvanis Suture-Product Status 43

Table 79: Galvanis Suture-Product Description 43

Table 80: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 81: TephaFLEX Absorbable Multifilament Fiber-Product Status 44

Table 82: TephaFLEX Absorbable Multifilament Fiber-Product Description 44

Table 83: TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 84: ELUTE Fiber-Smart Suture-Product Status 45

Table 85: ELUTE Fiber-Smart Suture-Product Description 45

Table 86: Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 46

Table 87: Nanosuture-Product Status 46

Table 88: Nanosuture-Product Description 46

Table 89: University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 47

Table 90: Angiogenic Suture-Product Status 47

Table 91: Angiogenic Suture-Product Description 47

Table 92: Visionary Medical Supplies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 93: Sutrazorb Absorbable PGA Suture-Product Status 48

Table 94: Sutrazorb Absorbable PGA Suture-Product Description 48

Table 95: VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Table 96: VitaSuture Wound Management System-Product Status 49

Table 97: VitaSuture Wound Management System-Product Description 49

Table 98: Glossary 123

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Advanced Suture

Archon Medical Technologies LLC

BioSurfaces, Inc.

CorMedix Inc

Ethicon US LLC

Indian Institute of Technology Bombay

Indian Institute of Technology Delhi

Innovation Pharmaceuticals Inc

Johns Hopkins University

Mellon Medical B.V.

MiMedx Group Inc

Nobles Medical Technology, Inc.

NuVascular Technologies Inc

Resorba GmbH

Scarless Laboratories Inc

Silver Bullet Therapeutics, Inc.

Tepha Inc

TissueGen Inc

Universidade Nova de Lisboa

University of North Carolina at Chapel Hill

Visionary Medical Supplies, Inc.

VitaThreads, LLC